Date:8/19/2009

net cash used by operating activities: - deferred income taxes 690,556 -970,614 847,950 -897,433 - Loss (income) on disposal fixed assets 2,434 -- -7,349 -- - stock-based compensation 61,540 16,635 128,043 33,271 - provision for doubtful debts 1,443,986 932,113 2,312,924 1,559,918 - depreciation of property, plant and equipment, and amortization of licenses 431,753 388,460 864,107 780,563 - research and development expenditures qualified for government grant -70,374 -126,829 -128,685 -130,848 Change in other assets and liabilities - accounts receivable 12,080,553 -9,218,834 14,543,552 13,369,079 - inventories -2,803,876 -865,187 -5,135,639 -2,314,630 - income tax refundable 712,224 -- -173,028 -- - prepaid expenses and deposits 224,922 -403,304 255,826 -84,290 - advance from stockpiling program 9,644,568 -- 9,644,568 -- - accounts payable and accrued liabilities 1,487,986 3,668,617 -1,283,789 4,142,407 Net cash provided by (used in) operating activities 8,135,498 -1,696,930 1,303,267 -3,099,297 Cash flows from (used in) financing activities Loan proceeds 16,074,281 -- 16,074,281 -- Loan repayment -- -- -- -- Proceeds from issuance of common stock -- 1,966 -- 9,815,265 Repurchase of common shares -16,189 -- -335,832 -- Loan to non-controlling shareholder of
'/>"/>

SOURCE Sinovac Biotech Ltd. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Related medicine news :

1. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
2. Sinovac Provides Support to Chinas Ministry of Health to Aid Earthquake Victims
3. Sinovac Announces that Government Investigation Rules Out Healives Role in Childs Death
4. Sinovac Reports Unaudited First Quarter 2009 Financial Results
5. Sinovac Schedules 2008 Annual General Meeting
6. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
7. Haemacure Reports Third Quarter 2007 Results
8. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. MDS Reports Third Quarter 2007 Results
11. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006